TY - CHAP
T1 - Role of lipids in Coxiella burnetii infection
AU - Gilk, Stacey D.
N1 - Funding Information:
I would like to thank Audrey Chong, Bob Heinzen, and Seth Winfree for critical reading of the manuscript. DHCR24 mice were generously provided by Quark Biotech (Israel). This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. +/−
PY - 2012
Y1 - 2012
N2 - Lipids are essential components of both eukaryotic and prokaryotic cells, serving diverse functions including energy metabolism and membrane structure. Intracellular vacuolar pathogens such as Coxiella burnetii require lipids for both normal bacterial functions as well as formation of the acidic, phagolysosomal-like parasitophorous vacuole (PV) surrounding the bacteria. As an intracellular pathogen, C. burnetii can acquire lipid through both de novo bacterial synthesis and subversion of host cell pools. The C. burnetii genome encodes enzymes required for de novo synthesis of fatty acids and phospholipids. The high percentage of branched fatty acids suggests C. burnetii modifies these molecules to generate a bacterial cell envelope that can resist the harsh environment of the PV, such as the acidic pH. In addition to fatty acids and their derivatives, C. burnetii requires isoprenoids, particularly sterols as the PV membrane is cholesterol-rich. With the exception of two eukaryote-like sterol reductases, C. burnetii does not have the capability to generate cholesterol, suggesting sterols are actively diverted from the host cell. While C. burnetii utilizes host cell lipids for membrane biogenesis and possibly energy, bacterial manipulation of host cell lipid signaling pathways may support establishment of the intracellular niche. For example, effectors secreted by the C. burnetii Type IV secretion system may either directly or indirectly modify host cell lipids. Further understanding of the lipid biosynthetic capabilities of C. burnetii, along with C. burnetii's manipulation of host cell lipids, will provide insight into the host-pathogen relationship.
AB - Lipids are essential components of both eukaryotic and prokaryotic cells, serving diverse functions including energy metabolism and membrane structure. Intracellular vacuolar pathogens such as Coxiella burnetii require lipids for both normal bacterial functions as well as formation of the acidic, phagolysosomal-like parasitophorous vacuole (PV) surrounding the bacteria. As an intracellular pathogen, C. burnetii can acquire lipid through both de novo bacterial synthesis and subversion of host cell pools. The C. burnetii genome encodes enzymes required for de novo synthesis of fatty acids and phospholipids. The high percentage of branched fatty acids suggests C. burnetii modifies these molecules to generate a bacterial cell envelope that can resist the harsh environment of the PV, such as the acidic pH. In addition to fatty acids and their derivatives, C. burnetii requires isoprenoids, particularly sterols as the PV membrane is cholesterol-rich. With the exception of two eukaryote-like sterol reductases, C. burnetii does not have the capability to generate cholesterol, suggesting sterols are actively diverted from the host cell. While C. burnetii utilizes host cell lipids for membrane biogenesis and possibly energy, bacterial manipulation of host cell lipid signaling pathways may support establishment of the intracellular niche. For example, effectors secreted by the C. burnetii Type IV secretion system may either directly or indirectly modify host cell lipids. Further understanding of the lipid biosynthetic capabilities of C. burnetii, along with C. burnetii's manipulation of host cell lipids, will provide insight into the host-pathogen relationship.
KW - Cholesterol biosynthesis
KW - Fatty acid synthesis
KW - Membrane composition
KW - Membrane fluidity
KW - Phospholipid synthesis
KW - Statin
KW - Sterol reductase
KW - Type IV secretion system
UR - http://www.scopus.com/inward/record.url?scp=84863763702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863763702&partnerID=8YFLogxK
U2 - 10.1007/978-94-007-4315-1_10
DO - 10.1007/978-94-007-4315-1_10
M3 - Chapter
C2 - 22711633
AN - SCOPUS:84863763702
SN - 9789400743144
T3 - Advances in Experimental Medicine and Biology
SP - 199
EP - 213
BT - Coxiella burnetii
A2 - Toman, Rudolf
A2 - Samuel, James
A2 - Heinzen, Robert
A2 - Mege, Jean-Louis
ER -